Loading...
Target Audience: Gastroenterologists and primary care providers
This updated, evidence-based guideline with graded recommendations incorporates advances in the field since the previous ACG guideline was published in 2007.
It has become clear that antibiotic resistance is a major determinant of eradication failure. New regimens are now proposed for both first-line and salvage therapies, and modifications of the drug doses and duration of therapy are addressed.
First-line treatments may include:
Quadruple bismuth-based therapy for 10 to 14 days
Concomitant (a proton-pump inhibitor plus three antibiotics) therapy for 10 to 14…